SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Jan-23 9:47 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 17-Jan-23 | Option Exercise | 402,529 | -- | -- | 815% 49.36K to 451.89K | |
10-Jan-23 9:19 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 06-Jan-23 | Grant | 261,718 | -- | -- | 40% 651.36K to 913.08K | |
10-Jan-23 9:19 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 06-Jan-23 | Payment of Exercise | 73,940 | $0.71 | $52,490.00 | (8%) 913.08K to 839.14K | |
30-Sep-22 9:48 PM View: | Idera Pharmaceuticals, Inc. (ACGN) | 28-Sep-22 | Grant | 651,364 | -- | -- | 100% 0 to 651.36K | |
12-Feb-04 10:00 PM View: | Guilford Pharmaceuticals Inc (GLFDE.OB) | 31-Dec-03 | Acquisition (other) | 781 | $3.84 | $3,000.60 | < 1% 136.16K to 136.94K | |
12-Feb-04 10:00 PM View: | Guilford Pharmaceuticals Inc (GLFDE.OB) | 31-Dec-03 | Acquisition (other) | 218 | $6.78 | $1,478.04 | < 1% 136.94K to 137.16K |